313 related articles for article (PubMed ID: 19752277)
1. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
Locke JB; Hilgers M; Shaw KJ
Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
Shaw KJ; Poppe S; Schaadt R; Brown-Driver V; Finn J; Pillar CM; Shinabarger D; Zurenko G
Antimicrob Agents Chemother; 2008 Dec; 52(12):4442-7. PubMed ID: 18838596
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
Louie A; Liu W; Kulawy R; Drusano GL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3453-60. PubMed ID: 21502615
[TBL] [Abstract][Full Text] [Related]
4. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
Locke JB; Hilgers M; Shaw KJ
Antimicrob Agents Chemother; 2009 Dec; 53(12):5275-8. PubMed ID: 19805557
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.
Locke JB; Finn J; Hilgers M; Morales G; Rahawi S; G C K; Picazo JJ; Im W; Shaw KJ; Stein JL
Antimicrob Agents Chemother; 2010 Dec; 54(12):5337-43. PubMed ID: 20837751
[TBL] [Abstract][Full Text] [Related]
6. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.
Locke JB; Morales G; Hilgers M; G C K; Rahawi S; José Picazo J; Shaw KJ; Stein JL
Antimicrob Agents Chemother; 2010 Dec; 54(12):5352-5. PubMed ID: 20837755
[TBL] [Abstract][Full Text] [Related]
7. Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I.
Huang Y; Xu Y; Liu S; Wang H; Xu X; Guo Q; Wu B; Gordeev MF; Wang W; Yuan Z; Wang M
Int J Antimicrob Agents; 2014 May; 43(5):418-22. PubMed ID: 24721233
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
Prokocimer P; Bien P; Deanda C; Pillar CM; Bartizal K
Antimicrob Agents Chemother; 2012 Sep; 56(9):4608-13. PubMed ID: 22687509
[TBL] [Abstract][Full Text] [Related]
9. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683
[TBL] [Abstract][Full Text] [Related]
10. Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
Betriu C; Morales G; Rodríguez-Avial I; Culebras E; Gómez M; López-Fabal F; Picazo JJ
Antimicrob Agents Chemother; 2010 May; 54(5):2212-5. PubMed ID: 20176900
[TBL] [Abstract][Full Text] [Related]
11. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
12. Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
Miller K; O'Neill AJ; Wilcox MH; Ingham E; Chopra I
Antimicrob Agents Chemother; 2008 Jun; 52(6):1940-4. PubMed ID: 18378719
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges.
Brown SD; Traczewski MM
Antimicrob Agents Chemother; 2010 May; 54(5):2063-9. PubMed ID: 20231392
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
Lepak AJ; Marchillo K; Pichereau S; Craig WA; Andes DR
Antimicrob Agents Chemother; 2012 Nov; 56(11):5916-22. PubMed ID: 22964254
[TBL] [Abstract][Full Text] [Related]
15. TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens.
Jones RN; Moet GJ; Sader HS; Mendes RE; Castanheira M
J Antimicrob Chemother; 2009 Apr; 63(4):716-20. PubMed ID: 19218276
[TBL] [Abstract][Full Text] [Related]
16. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
Meka VG; Gold HS; Cooke A; Venkataraman L; Eliopoulos GM; Moellering RC; Jenkins SG
J Antimicrob Chemother; 2004 Oct; 54(4):818-20. PubMed ID: 15347637
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
Candel FJ; Morales G; Picazo JJ
Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
[TBL] [Abstract][Full Text] [Related]
18. Mutation in the L3 Ribosomal Protein Could Be Associated with Risk of Selection of High-Level Linezolid-Resistant Staphylococcus epidermidis Strains.
Rouard C; Aslangul E; Rivière A; Deback C; Butel MJ; Doucet-Populaire F; Bourgeois-Nicolaos N
Microb Drug Resist; 2017 Jun; 23(4):462-467. PubMed ID: 27754824
[TBL] [Abstract][Full Text] [Related]
19. Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene.
Locke JB; Zuill DE; Scharn CR; Deane J; Sahm DF; Denys GA; Goering RV; Shaw KJ
Antimicrob Agents Chemother; 2014 Nov; 58(11):6592-8. PubMed ID: 25155597
[TBL] [Abstract][Full Text] [Related]
20. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
